Markedly different rates and resistance profiles exhibited by seven commonly used and newer β-lactams on the selection of resistant variants of Enterobacter cloacae

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 1, 1999, Pages 55-60

  Chan, Wai C ^a   Li, Ronald ^a   Ling, Julia M ^a   Cheng, Augustine F ^a   Schentag, Jerome J ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFAMANDOLE; CEFEPIME; CEFOPERAZONE; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; IMIPENEM; MEROPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CROSS RESISTANCE; ENTEROBACTER CLOACAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CEFAMANDOLE; CEFOPERAZONE; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; ENTEROBACTER CLOACAE; IMIPENEM; MICROBIAL SENSITIVITY TESTS; THIENAMYCINS;

EID: 0032901445     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.1.55     Document Type: Article

References (17)

1. Gaynes, R. P., Culver, D. H., Horan, T. C., Henderson, T. S., Toison, J. S. & Martone, W. J. (1992). Trends in methicillin-resistant Staphylococcus aureus in United States hospitals. Infectious Diseases and Clinical Practices 2, 452-5.
2. Cohen, M. L. (1992). Epidemiology of drug resistance: implications for a post-anti-microbial area. Science 257, 1050-5.
3. Wiedemann, B. & Atkinson, B. A. (1991). Susceptibility to antibiotics: species incidence and trends. In Antibiotics in Laboratory Medicine, 3rd edn, (Lorian V., ed), pp. 962-1062. Williams and Wilkins, Baltimore, MD.
4. Schentag, J. J., Hyatt, J. M., Carr, J. B., Paladino, J. A., Birmingham, M. C., Zimmer, G. S. et al. (1998). Genesis of methicillin resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clinical Infectious Diseases 26, 1204-14.
5. McGowan, J. E. (1983). Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Review of Infectious Diseases 5, 1033-48.
6. Pechère, J. C., Marchou, B., Michea-Hamzehpour, M. & Auckenthaler, R. (1986). Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. Journal of Antimicrobial Chemotherapy 17, Suppl. A, 11-8.
7. Michea-Hamzehpour, M., Auckenthaler, R., Regamey, P. & Pechère, J. C. (1987). Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrobial Agents and Chemotherapy 31, 1803-8.
8. Milatovic, D. & Braveny, I. (1987). Development of resistance during antibiotic therapy. European Journal of Clinical Microbiology 6, 234-44.
9. Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P. et al. (1991). Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Annals of Internal Medicine 115, 585-90.
10. Stapleton, P., Shannon, K. & Phillips, I. (1995). The ability of β-lactam antibiotics to select mutants with depressed β-lactamase synthesis from Citrobacter freundii. Journal of Antimicrobial Chemotherapy 36, 483-96.
11. Fung-Tomc, J. C., Gradelski, E., Huczko, E., Dougherty, T. J., Kessler, R. E. & Bonner, D. P. (1996). Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 40, 1289-93.
12. Gaston, M. A. (1988). Enterobacter, an emerging nosocomial pathogen. Journal of Hospital Infection 11, 197-208.
13. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A3. NCCLS, Villanova, PA.
14. Ehrhardt, A. F., Sanders, C. C., Romero, J. R. & Leser, J. S. (1996). Sequencing and analysis of four new Enterobacter ampD alleles. Antimicrobial Agents and Chemotherapy 40, 1953-6.
15. Buscher, K. H., Cullmann, W., Dick, W. & Stieglitz, M. (1987). Selection frequency of resistant variants by various /Mactam antibiotics in clinical Enterobacter cloacae isolates. Chemotherapy 33, 40-51.
16. Michea-Hamzehpour, M. & Pechère, J. C. (1989). How predictable is development of resistance after beta-lactam therapy in Enterobacter cloacae infection? Journal of Antimicrobial Chemotherapy 24, 387-95.
17. Rasmussen, B. A. & Bush, K. (1997). Carbapenem-hydrolysing β-lactamases. Antimicrobial Agents and Chemotherapy 41, 223-32.